On December 24, 2021, Abpro Bio Co., Ltd. closed the transaction. The company amended the terms of the transaction and issued 7,159,904 shares at a price of KRW 838 for gross proceeds of KRW 5,999,999,552. The transaction involved participation from returning investor Veritas Fund.